PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,552,000 | +31.2% | 40,000 | +100.0% | 0.57% | +25.7% |
| Q2 2018 | $1,183,000 | -30.5% | 20,000 | -20.0% | 0.46% | -42.7% |
| Q1 2018 | $1,701,000 | -50.8% | 25,000 | -28.6% | 0.79% | -38.2% |
| Q4 2017 | $3,460,000 | +44.5% | 35,000 | +75.0% | 1.28% | +57.5% |
| Q3 2017 | $2,395,000 | +37.0% | 20,000 | 0.0% | 0.82% | +27.3% |
| Q2 2017 | $1,748,000 | +56.6% | 20,000 | -33.3% | 0.64% | +23.1% |
| Q1 2017 | $1,116,000 | +21.2% | 30,000 | 0.0% | 0.52% | +18.5% |
| Q4 2016 | $921,000 | – | 30,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |